Skip to content
The Policy VaultThe Policy Vault

Evusheld (tixagevimab and cilgavimab) — Medica

Coronavirus Disease 2019 (COVID-19), pre-exposure prophylaxis

Initial criteria

  • Approval is not recommended for any use; Evusheld is not authorized due to lack of clinical efficacy and removal of EUA by FDA.